• Publications
  • Influence
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
A number of recent reports have demonstrated that only CD133-positive cancer cells of glioblastoma multiforme (GBM) have tumor-initiating potential. These findings raise an attractive hypothesis thatExpand
MET signaling regulates glioblastoma stem cells.
Glioblastomas multiforme (GBM) contain highly tumorigenic, self-renewing populations of stem/initiating cells [glioblastoma stem cells (GSC)] that contribute to tumor propagation and treatmentExpand
Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.
Frequent discrepancies between preclinical and clinical results of anticancer agents demand a reliable translational platform that can precisely recapitulate the biology of human cancers. AnotherExpand
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
RNA interference is a powerful strategy that inhibits gene expression through specific mRNA degradation. In vivo, however, the application of small interfering RNAs (siRNAs) is severely limited byExpand
Trans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage
Radiation therapy is an indispensable therapeutic modality for various brain diseases. Though endogenous neural stem cells (NSCs) would provide regenerative potential, many patients neverthelessExpand
Wnt activation is implicated in glioblastoma radioresistance
Glioblastoma (GBM) patients have dismal median survival even with the most rigorous treatments currently available. Radiotherapy is the most effective non-surgical therapy for GBM patients; however,Expand
Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer.
Neural stem cells (NSCs) led to the development of a novel strategy for delivering therapeutic genes to tumors. NSCs expressing rabbit carboxyl esterase (F3.CE), which activates CPT-11, significantlyExpand
Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
BACKGROUND Despite significant improvements in colon cancer outcomes over the past few decades, preclinical development of more effective therapeutic strategies is still limited by the availabilityExpand
KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
  • S. Woo, Y. Ham, +5 authors D. Nam
  • Biology, Medicine
  • BioMed research international
  • 10 September 2014
Standard treatment for glioblastoma comprises surgical resection, chemotherapy with temozolomide, and radiotherapy. Nevertheless, majority of glioblastoma patients have recurrence from resistance toExpand
Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
One of the most detrimental hallmarks of glioblastoma multiforme (GBM) is cellular invasiveness, which is considered a potential cause of tumor recurrence. Infiltrated GBM cells are difficult toExpand